Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic Anemia
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Oct 01, 2015
- Source ID
- 10.1016/j.bbmt.2015.05.023
Entities
People
- Alvaro Urbano-ispizua
- Ami A Shah
- Amin M. Alousi
- Ayman Saad
- Baldeep Wirk
- Betty K. Hamilton
- Corey S. Cutler
- Daniel R. Couriel
- David I. Marks
- Gerard Socie
- Görgün Akpek
- Joseph H. Antin
- Martin S. Tallman
- Mary E.d. Flowers
- Melhem M. Solh
- Michael T. Hemmer
- Mitchell S Cairo
- Mohamed A Kharfan-Dabaja
- Mukta Arora
- Nelson J Chao
- Olle T.h. Ringdén
- Paul J. Martin
- Ran Reshef
- Robert J. Hayashi
- Robert Peter Gale
- Stephen R. Spellman
- Taiga Nishihori
- Takanori Teshima
- Tao Wang
- Vikas Gupta
- Yoshihiro Inamoto
Organizations
- ARIAD Pharmaceuticals
- Actinium Pharmaceuticals (United States)
- Amgen
- Blue Cross Blue Shield Association
- Celgene
- Elevance Health, Inc.
- Fred Hutchinson Cancer Center
- GSK
- Health Research
- HistoGenetics (United States)
- Incyte
- Kiadis Pharma (Netherlands)
- Leukemia & Lymphoma Society
- Medical College of Wisconsin
- Merck & Co.
- Miltenyi Biotec
- National Cancer Institute
- National Heart, Lung, and Blood Institute
- National Institute of Allergy and Infectious Diseases
- National Marrow Donor Program
- Office of Naval Research
- Onyx Pharmaceuticals
- Osiris Therapeutics
- Otsuka (United States)
- Roche (United States)
- Roswell Park Comprehensive Cancer Center
- Sanofi-Aventis
- Seagen
- Sigma-Tau Pharmaceuticals (United States)
- St. Baldrick's Foundation
- StemCyte
- Swedish Orphan Biovitrum
- Tarix Orphan (United States)
- Terumo BCT (United States)
- University of Minnesota
- University of Utah